Development and content validation of a surgical safety checklist for operating theatres that use robotic technology

被引:22
作者
Ahmed, Kamran [1 ]
Khan, Nuzhath [1 ]
Khan, Mohammed Shamim [1 ]
Dasgupta, Prokar [1 ]
机构
[1] Guys Hosp, Univ London Kings Coll, MRC Ctr Transplantat, Dept Urol,Kings Hlth Partners, London SE1 9RT, England
关键词
urology; patient safety; checklist; error; adverse event; communication; FAILURE MODE; ADVERSE EVENTS; RISK ANALYSIS; HEALTH-CARE; ANESTHESIA;
D O I
10.1111/bju.12010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To identify and assess potential hazards in robot-assisted urological surgery. To develop a comprehensive checklist to be used in operating theatres with robotic technology. Methods Healthcare Failure Mode and Effects Analysis (HFMEA), a risk assessment tool, was used in a urology operating theatre with innovative robotic technology in a UK teaching hospital between June and December 2011. A 15-member multidisciplinary team identified 'failure modes' through process mapping and flow diagrams. Potential hazards were rated according to severity and frequency and scored using a 'hazard score matrix'. All hazards scoring >= 8 were considered for 'decision tree' analysis, which produced a list of hazards to be included in a surgical safety checklist. Results Process mapping highlighted three main phases: the anaesthesia phase, the operating phase and the postoperative handover to recovery phase. A total of 51 failure modes were identified, 61% of which had a hazard score >8. A total of 22 hazards were finalised via decision tree analysis and were included in the checklist. The focus was on hazards specific to robotic urological procedures such as patient positioning (hazard score 12), port placement (hazard score 9) and robot docking/de-docking (hazard score 12). Conclusions HFMEA identified hazards in an operating theatre with innovative robotic technologies which has led to the development of a surgical safety checklist. Further work will involve validation and implementation of the checklist.
引用
收藏
页码:1161 / 1174
页数:14
相关论文
共 33 条
[1]   Radiology Failure Mode and Effect Analysis: What Is It? [J].
Abujudeh, Hani H. ;
Kaewlai, Rathachai .
RADIOLOGY, 2009, 252 (02) :544-550
[2]   Use of failure mode and effects analysis in improving the safety of iv drug administration [J].
Adachi, W ;
Lodolce, AE .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (09) :917-920
[3]   Revisiting patient safety for innovative urological surgery [J].
Ahmed, Kamran ;
Sharma, Sonia ;
Khan, Shahid A. A. ;
Cahill, Declan ;
Kumar, Pardeep ;
Challacombe, Ben ;
Kirby, Roger ;
Khan, Mohammed Shamim ;
Dasgupta, Prokar .
TRENDS IN UROLOGY & MENS HEALTH, 2012, 3 (04) :17-22
[4]   Complications Associated With Patient Positioning in Urologic Surgery [J].
Akhavan, Ardavan ;
Gainsburg, Daniel M. ;
Stock, Jeffrey A. .
UROLOGY, 2010, 76 (06) :1309-1316
[5]   Improving the Safety of Chemotherapy Administration: An Oncology Nurse-Led Failure Mode and Effects Analysis [J].
Ashley, Laura ;
Dexter, Rachel ;
Marshall, Fay ;
McKenzie, Brenda ;
Ryan, Maggie ;
Armitage, Gerry .
ONCOLOGY NURSING FORUM, 2011, 38 (06) :E436-E444
[6]  
Catchpole K, 2009, SURG SAFETY CAN BE I
[7]   Nerve injury associated with anesthesia - A closed claims analysis [J].
Cheney, FW ;
Domino, KB ;
Caplan, RA ;
Posner, KL .
ANESTHESIOLOGY, 1999, 90 (04) :1062-1069
[8]   Applying HFMEA to Prevent Chemotherapy Errors [J].
Cheng, Chia-Hui ;
Chou, Chia-Jen ;
Wang, Pa-Chun ;
Lin, Hsi-Yen ;
Kao, Chi-Lan ;
Su, Chao-Ton .
JOURNAL OF MEDICAL SYSTEMS, 2012, 36 (03) :1543-1551
[9]   Effect of a Comprehensive Surgical Safety System on Patient Outcomes. [J].
de Vries, Eefje N. ;
Prins, Hubert A. ;
Crolla, Rogier M. P. H. ;
den Outer, Adriaan J. ;
van Andel, George ;
van Helden, Sven H. ;
Schlack, Wolfgang S. ;
van Putten, M. Agnes ;
Gouma, Dirk J. ;
Dijkgraaf, Marcel G. W. ;
Smorenburg, Susanne M. ;
Boermeester, Marja A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) :1928-1937
[10]  
Delgado Silveira E, 2012, Farm Hosp, V36, P24, DOI 10.1016/j.farma.2010.12.002